Ready to buy? Check current prices on Amazon and compare deals before you decide.
Navigating perimenopause can bring a range of new experiences, from shifts in mood and energy to changes in sleep patterns. As women seek ways to support their well-being during this transition, interest in botanical supplements like ashwagandha has grown.
Ashwagandha (Withania somnifera) is an herb traditionally used in Ayurvedic practices. Today, several standardized extracts are available, with KSM-66 and Sensoril being two prominent options. This article will explore the current evidence surrounding these extracts, particularly their relevance for women in perimenopause.
Understanding Ashwagandha Extracts: KSM-66 and Sensoril
Ashwagandha extracts are standardized to contain specific levels of active compounds called withanolides, which are thought to be responsible for many of the herb’s potential effects [1]. The standardization process aims to ensure consistency in the extract’s composition.
KSM-66 and Sensoril are both branded, full-spectrum ashwagandha root extracts, but they differ in their extraction methods and the concentration of withanolides. KSM-66 is standardized to contain at least 5% withanolides, while Sensoril is standardized to a higher percentage, typically 10% withanolides, and also includes some leaf extract in its composition. These differences may influence their specific effects and applications.
Ashwagandha for Perimenopausal Symptoms: What the Research Suggests
Perimenopause is characterized by fluctuating hormone levels, which can contribute to various symptoms such as mood changes, sleep disturbances, and occasional hot flashes. Some research has explored ashwagandha’s potential role in supporting women during this time.
A randomized, double-blind, placebo-controlled study investigated the effect of an ashwagandha root extract (specifically, Shoden®) on climacteric symptoms in women during perimenopause. Participants receiving the ashwagandha extract reported improvements in some perimenopausal symptoms, including hot flashes, night sweats, and mood, compared to the placebo group [2]. While this study used a different extract, it points to the potential area of benefit for ashwagandha in perimenopausal symptom support. More research specifically on KSM-66 and Sensoril for a broad range of perimenopausal symptoms would be beneficial.
Ashwagandha and Stress Support
Stress can be a significant factor for many women, and perimenopause can sometimes amplify feelings of overwhelm. Ashwagandha is often recognized for its adaptogenic properties, meaning it may help the body adapt to stress.
Several studies have examined ashwagandha’s impact on stress and anxiety. A systematic review and meta-analysis of multiple studies found that Withania somnifera may have a role in supporting individuals experiencing anxiety and insomnia [3]. Another randomized, double-blind, placebo-controlled trial explored a standardized ashwagandha root extract (Witholytin®) in adults experiencing high stress and fatigue, noting potential benefits [4].
Specifically for KSM-66, research has indicated its potential to help manage stress. Similarly, Sensoril has also been studied for its potential effects on stress. While direct comparative studies between KSM-66 and Sensoril on stress markers in perimenopausal women are limited, both extracts have shown promise in general populations for supporting the body’s response to stress.
Ashwagandha and Sleep Quality
Sleep disturbances are common during perimenopause, with many women experiencing difficulty falling or staying asleep. Ashwagandha has been investigated for its potential to support restful sleep.
A double-blind, randomized, placebo-controlled study found that an ashwagandha root extract may be helpful for individuals experiencing insomnia and anxiety [5]. The systematic review and meta-analysis also reinforced the potential role of Withania somnifera for insomnia [3]. While these studies don’t specifically compare KSM-66 and Sensoril, they suggest that ashwagandha, in general, may offer support for sleep quality.
Both KSM-66 and Sensoril have been included in studies related to sleep, with some suggesting potential benefits for sleep parameters. The specific mechanisms and comparative efficacy between the two extracts for sleep in perimenopausal women require further dedicated research.
Ashwagandha and Cognitive Function
Some women report ‘brain fog’ or changes in cognitive function during perimenopause. Emerging research has looked into ashwagandha’s potential impact on cognitive health.
A study on the efficacy and safety of ashwagandha root extract in improving memory and cognitive functions suggested potential benefits in this area [6]. While this research provides an indication, more specific studies focusing on perimenopausal women and direct comparisons between KSM-66 and Sensoril for cognitive support are needed to draw firm conclusions.
Safety Considerations and Which Might Be ‘Best’
Ashwagandha is generally considered to be well-tolerated by many individuals, with a comprehensive review noting its safety profile [1]. However, as with any supplement, potential side effects can occur, and individual responses may vary. Reported side effects are typically mild and may include gastrointestinal upset or drowsiness [1].
When considering KSM-66 versus Sensoril for perimenopause, there isn’t definitive evidence to declare one ‘best’ over the other for all women. Both are well-researched, standardized extracts with evidence supporting their use in areas relevant to perimenopausal well-being, such as stress reduction and sleep support. The choice may come down to individual preference, specific formulation, and how one’s body responds.
The key differences lie in their withanolide concentration and the inclusion of leaf extract in Sensoril. Some individuals may prefer KSM-66 for its exclusive root extract and 5% withanolide standardization, while others might opt for Sensoril due to its higher withanolide content. It’s important to select a reputable brand and follow dosage instructions.
References
- Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021
- Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study. The journal of obstetrics and gynaecology research, 2021
- Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis. Human psychopharmacology, 2024
- Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial. Journal of psychopharmacology (Oxford, England), 2023
- Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus, 2019
- Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. Journal of dietary supplements, 2017
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
